Reforming Average Sales Price-Based Reimbursement For Infused Biosimilars Ryan N. Hansen Joshua A. Roth Victoria W. Dayer Sean D. Sullivan November 3, 2025

https://www.healthaffairs.org/content/forefront/considerations-reform-average-sales-price-based-reimbursement-infused-biosimilars